NEW YORK (GenomeWeb) – German non-profit charitable foundation Stefan-Morsch-Stiftung today announced a collaboration with Dutch molecular diagnostics firm GenDx to increase the HLA typing resolution level of new donors in the non-profit's registry.

Stefan-Morsch-Stiftung will implement GenDx's high-resolution HLA typing method into its next-generation sequencing typing workflow as part of the deal. GexDx's approach combines its HLA typing kits with its NGSengine analysis software.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.